Determining the appropriate retatrutide amount is critically necessary for obtaining desired outcomes . Initially, individuals typically commence with a low dose of around 2.4 mg, administered each week via subcutaneous . This initial amount is then gradually boosted every four weeks , up to a peak quantity of 10.8 mg, according to individual reac